|
| We would have to see who funded this study. If it was big pharma then you have a point, if it was privately funded you wouldn't. In about 2021 I was browsing through PubMed and found a 2016 study showing ivermectin efficacy against chemo resistant triple negative breast cancer. It showed that 75% of women who used it had their cancer go into remission, on the negative side it was a small study with just 8 participants. I don't follow breast cancer research or methods but I cannot imagine why this wouldn't be front page news an start immediate funding of ivermectin and cancer research. There is a saying I've heard, science progresses at the rate that the old scientists die off. | |
|